A Smart + Strong Site
Subscribe to:
POZ magazine

Back to home » Treatment News » Top Stories

Most Popular Stories
Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples
FDA Approves New Single-Tablet HIV Regimen, Triumeq
Life Expectancy for Young People With HIV Is Nearly Normal
A 15-Year Jump in Life Expectancy for People With HIV
Scientists Devise Method of Snipping HIV From Immune Cells
Monkey HIV Vaccine Success Opens Door for Human Trials
HIV Combo Pill Less Toxic Thanks to New Form of Tenofovir
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to news@aidsmeds.com.

Click here for more news


October 29, 2012

New Highly Sensitive, Low-Cost HIV Test Gives Early, Naked Eye Results

English researchers have developed a groundbreaking new HIV test with manifold benefits that include results visible to the naked eye, a reduced “window period” after infection and a dramatically lowered cost that could greatly benefit developing nations. According to a paper published in Nature Nanotechnology, the research team from Imperial College London has developed a prototype test that, in contrast to the standard ELISA nucleic acid-based test, analyzes blood serum for an HIV biomarker known as p24. If the biomarker is present, a reaction within a vial of solution causes nanoparticles to draw together into irregular clusters and develop a visible blue color. Negative results are visibly red when these nanoparticles instead separate into spherical shapes. Because the test is able to detect even the most minute particles of p24, it promises to significantly reduce the window period—the period directly after infection when tests might fail to detect antibodies and thus give false negative results. Furthermore, the new test is one-tenth the cost. To that end, the researchers intend to team with nonprofit global health groups to put the test into wide use in low-income countries.

For a copy of the study, click here

To read the press release, click here

Search: HIV, HIV test, ELISA, antibody, nanoparticle, p24, biomarker, Imperial College London, early results, lowered cost, red, blue, Nature Nanotechnology

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team reviews all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (1 total)

[Go to top]

Quick Links
About HIV and AIDS
The Cure
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Conference Coverage
Health Services Directory
POZ Magazine
AIDSmeds on Twitter

Conference Coverage

XX International AIDS Conference
(AIDS 2014)
Melbourne, Australia
July 20 - 25, 2014

21st Conference on Retroviruses and Opportunistic Infections
(CROI 2014)
Boston, MA
March 3 - 7, 2014

7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS 2013)
Kuala Lumpur, Malaysia
June 30 - July 3, 2013

more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.